PSX
40
-4
HOG
50
6
MAR
60
7
VNO
57
-2
IFF
56
-3
ZTS
56
-2
TGNA
48
-2
MMC
58
-2
XYL
54
-4
NTRS
49
-5
FDX
29
-21
UNH
53
-3
UA
32
8
L
55
-4
CL
58
2
FTI
82
4
UNP
40
-2
PNC
57
-2
SJM
38
-3
UAL
56
2
PSX
40
-4
HOG
50
6
MAR
60
7
VNO
57
-2
IFF
56
-3
ZTS
56
-2
TGNA
48
-2
MMC
58
-2
XYL
54
-4
NTRS
49
-5
FDX
29
-21
UNH
53
-3
UA
32
8
L
55
-4
CL
58
2
FTI
82
4
UNP
40
-2
PNC
57
-2
SJM
38
-3
UAL
56
2
Financhill
Back

Nu Skin Enterprises Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
22

NUS
Nu Skin Enterprises

Last Price:
7.07
Seasonality Move:
2.71%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
22
Nu Skin Enterprises (NUS) is a Sell

Is Nu Skin Enterprises a Buy, Sell or Hold?

  • The current Nu Skin Enterprises [NUS] share price is $7.06. The Score for NUS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • NUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NUS Stock Price Chart

What is Nu Skin Enterprises's stock price today?

  • The Nu Skin Enterprises share price today is $7.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUS is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

NUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 29.09 Sell
Chaikin Money Flow: -7783484 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.41 - 9.53) Sell
Bollinger Bands (100): (8.98 - 12.82) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

NUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.36 Sell
20-day SMA: 8.16 Sell
50-day SMA: 9.42 Sell
200-day SMA: 13.23 Sell
8-day EMA: 7.37 Sell
20-day EMA: 8.02 Sell
50-day EMA: 9.2 Sell
200-day EMA: 13.73 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Nu Skin Enterprises Earnings Growth & NUS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.42 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.97 per share, and an increase next year of $0.31 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Nu Skin Enterprises Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):